PBTC-051 - Phase I Study to Evaluate the Safety and Tolerability of the CD40 Agonistic Monoclonal Antibody APX005Min Pediatric Subjects with Recurrent/Refractory Brain Tumors and Newly Diagnosed Brain Stem Glioma

Project: Research project

Project Details

StatusActive
Effective start/end date11/15/185/31/23

Funding

  • St. Jude Children's Research Hospital
  • Apexigen